QACV attended the CDER SBIA Training Symposium

FDA, MHRA and Health Canada GCP and Pharmacovigilance

Our team had the privilege of engaging with industry experts, regulatory authorities, and fellow stakeholders in an enriching exchange of insights and best practices.

The February symposium is instrumental in enhancing industries understanding of regulatory expectations and industry trends in GCP and Pharmacovigilance compliance. QACV is committed to utilizing this knowledge when supporting our clients compliance initiatives.

For more information on how QACV Consulting can support your pharmacovigilance needs, please contact us at contact@qacvconsulting.com.